Knowledge that moves
with the pace of AI.
A daily-curated hub of AI lectures, journal entries, and news from the Intelligence Synthesis network — covering AI foundations, marketing, programming, and medical applications.
AI Journal — Latest
View all →Can a causal graph explain why a reinforcement learning agent acted? ── A preprint proposing CausalXRL, which learns the causal structure behind an agent's decisions and returns explanations at more than one level
Where do AI agents that act before being asked go wrong? ── A preprint introducing HALO, in which experts graded proactive agents' responses in detail and found that premature and excessive interventions caused most rejections
Before running heavy reasoning, let a light model estimate whether it is worth it ── A preprint that formalises a loop in which System-1 screens candidates and System-2 executes them, and ties the possible saving to the density of useful candidates
Does Agent Memory Beat Simply Searching the Raw History? ── Memory Tax, a preprint that compares dedicated memory systems with naive RAG and separates what memory gains from what it loses
Making Professional Tasks Executable Before Training on Them ── WorkFactory, a preprint on planning the information a task needs and repairing defects through trial runs
Can Agents Post-Train a Model Across Several Domains at Once? ── ParetoRSI-Gym, a preprint proposing an environment that varies only the data and measures results in five domains
The file is genuine, yet the model cannot write code ── A preprint that functionally tests quantized LLMs in public registries and reports low-bit failures that calibration can reverse
When AI agents train a model and people grade it, what actually improves? ── A preprint on RSI Arena, a two-stage study in which ten frontier models post-train a language model and then receive human comparison records and votes
AI News — Daily Reports
View all →Anthropic's amended IPO statement is the biggest source.
Revenue for the third quarter reached approximately $17 billion, while losses were approximately $23 billion, and AI-related spending commitments are reported t…
Anthropic's IPO (reportedly valued at $2 trillion) was the biggest topic in the market, and DeepSeek's announc…
on for coding agents. The picture is clearly changing, with AI boosting Meta's ad revenue while encroaching on Google search. On the employment front, companies…
Doubts about the sustainability of AI investment suddenly surfaced.
OpenAI's funding goal was lowered by about $10 billion, and Alphabet reportedly lost about $500 billion in market capitalization in one day. Meta has a cash flo…
- Anthropic's IPO prospectus (S-1) has been released, and the industry is focused on debate over risk descript…
- On the other hand, concerns about a bubble are increasing, such as ``plummeting tech stocks'', ``AI panic'', and ``questions about profitability ($1trn questi…
Anthropic's IPO has been heavily reported in multiple media outlets, with reports stating that the company's v…
rtunity.'' Google was reported to have topped the benchmark with Gemini 4 Carbon, but revenue from AI search fell short of expectations, and Alphabet's market c…
The commentary surrounding Anthropic's IPO filing (Michael Burry's criticism, Elizabeth Warren's questionnaire…
Google launched Gemini 4 Carbon, opening up Gemini and Search to external apps and AI agents. While layoffs due to AI are spreading around the world, AI computi…
Anthropic's IPO documents (about 100 pages of risk list, voting structure, need for additional capital) are th…
In parallel, OpenAI announced three AI discoveries in mathematics, computer science, and physics, and Google released Genie 4. Large companies such as Microsoft…
The biggest news is that Anthropic has filed an S-1 with the SEC, moving toward one of the largest IPOs in his…
At the same time, Microsoft's early retirement proposal for about 60,000 employees, Meta's $95B AI infrastructure procurement, Musk's $40B chip debt disclosure,…
Lecture Programs
Join the conversation.
Where pharma meets AI.
AI Pharma Forum is the dedicated discussion space for practitioners working at the intersection of pharmaceuticals and artificial intelligence. Compare regulatory interpretations, share field experience, and stay ahead of weekly developments.
- Discuss AI applications in regulatory review
- Share field notes on promotional material compliance
- Compare prompts, workflows, and tooling
- Surface emerging risks before they reach the FDA / PMDA
- Connect with peers across pharma, agencies, and academia
- Get notified when new Intelligence Synthesis content drops
Visitors: same IP counted once per 30 days · Page Views: total page opens